Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA), Inc. 16th Annual Scientific Conference and Exposition September 22-25, 2022
Conference Theme: Drug Discovery, Development and Equitable Healthcare Delivery in a Changing Global Environment Nova Southeastern University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of Continuing Pharmacy Education (CPE). This program has been assigned the following Universal Activity Numbers, 0092-0000-20-211-L04-P to 0092-0000-20-233-L04-P and has been accredited for 12 contact hours (1.2 CEUs). Attendees must register for the Conference, sign-in when required, actively participate throughout each activity, and complete and sign the Attendance Form (with an NABP ID Number and birthdate) to receive credit. Participant’s earned credits will be posted to the CPE Monitor Website 4 to 6 weeks after receipt of all Convention paperwork. All requests for Continuing Pharmacy Education Credits must be turned in by November 20, 2022. Renaissance Tampa International Plaza Hotel 4200 Jim Walter Blvd, Tampa, FL 33607
Visit www.nappsa.org for more information.
THURSDAY, SEPTEMBER 22, 2022 10:00a – 5:30p | Registration | 12:30p –5:30p | Session #100: Pharmacy Education (Venue: TBD) | 12:30p–12:40p | Welcome Address: Teresa Pounds, PharmD, President, Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA) Inc., Durham, NC, USA. Cyril Usifo; BPharm PhD, Pharmacist Society of Nigeria and University of Benin, Benin City, Nigeria | 12:40p – 2:30p | Session #100: Universal Activity Number: 0092-0000-22-200-L04-P (0.20 CEUs) Knowledge-Based Activity. Future of Pharmacy Education: Challenges and Innovations for Success, Part 1 |
| Moderators: Ifeanyi G. Egbunike-Chukwuma, PharmD, University of Maryland Medical Center Midtown Campus, Baltimore, MD, USA. Uche Ndefo, PharmD, Texas Southern University, Houston, TX, USA. | 12:40p – 1:25p | #100A1: Future of Pharmacy Education: Challenges and Innovations for Success Kevin Sneed, PharmD, University of South Florida Taneja College of Pharmacy, Tampa, FL, USA. | 1:30p – 2:15p | #100A2: Restructuring Nigeria’s Pharmacy Education and Developing Pharmacist Competencies in Non-traditional Roles Ahmed Tijjani Mora, MBA, PhD, Pharmacists Council of Nigeria, Abuja, Nigeria. | 2:15p-2:30p | Break | 2:30p – 5:00p | Session #100: Universal Activity Number: 0092-0000-22-207-L04-P (0.25 CEUs) Application-Based Activity. Future of Pharmacy Education: Challenges and Innovations for Success, Part 2 | 2:30p – 3:00p | #100A3: Innovations in Community Pharmacy Practice in the USA. Chidebelu Ufodike, PharmD, Walgreen, Deerfield, IL, USA. | 3:00p – 3:30p | #100A4: Implementation of Pharmaceutical Care in Pharmacy Practice: A Collaborative Initiative in Nigeria. Azuka Oparah, MPharm, MBA, MPH, PhD, University of Benin, Benin. Nigeria. | 3:30p – 4:00p | #100A5: Educational Programs and Opportunities for Interdisciplinary Healthcare Professionals. Chika P. Duru, DNP, Kaiser Permanente, CA, USA. | 4:00p – 4:30p | #100A6: Career Opportunities for Pharmaceutical Scientists in the USA: Finding the Right Path. Nonye Onyewuenyi, PhD, Sandoz-Novartis Pharmaceuticals, Princeton, NJ, USA. | 4:30p – 5:00p | #100A7: Workforce Solutions for Pharmacy Practice in the USA: Thinking Outside the Box. Nkem P. Nonyel, PharmD, MPH, Howard University College of Pharmacy, Washington DC, USA. | 5:10p - 5:20p | Break | 5:20p – 6:30p | Session #100A: Universal Activity Number: 0092-0000-22-208-L04-P (0.075 CEUs) Knowledge-Based Activity. Future of Pharmacy Education: Challenges and Innovations for Success, Part 3 | 5:20p – 6:30p | Panel Discussion: Challenges and Innovations in Pharmacy and Pharmaceutical Sciences Education Okezie I. Aruoma, MBA, PhD, DSc, California State University Los Angeles, Los Angeles and Global PharmHealth Associates, Long Beach, CA, USA. Ifeanyi Egbunike-Chukwuma, PharmD, University of Maryland Medical Center Midtown Campus, Baltimore, MD, USA. Uche Ndefo, PharmD, Texas Southern University, Houston, TX, USA. Teresa Pounds, PharmD, President, Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA) Inc., Durham, NC, USA. Rukayyatu Gurin PhD, Senior Special Assistant to the President on Administration and Women Affairs in the Office of the First Lady of Nigeria, Abuja, Nigeria. Plus all the speakers. | 6:30p | Welcome Reception & Networking. |
FRIDAY, SEPTEMBER 23, 2022
7:00a – 5:00p | Registration | 8:00a – 8:45a | Registration and Breakfast | 8:45a – 9:00a | Commencement and Opening Address and introduction of the Keynote Speaker: Teresa Pounds, PharmD, President, Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA) Inc., Durham, NC, USA. | 9:00a – 12:00 pm | Session # 200: Universal Activity Number: 0092-0000-22-201-L04-P (0.30 CEUs) Knowledge-Based Activity. Pharmaceutical Sciences Forum I: Vaccines and Pharmaceutical Products from Clinical Studies to Bedside. | 9:00a – 10:00a | #200A1: Plenary Keynote Address: Health Care Delivery in Nigeria Health Care Delivery in Nigeria and Collaborations with Organizations in the Diaspora. Her Excellency, Hajiya Aisha Muhammadu Buhari, First Lady of the Federal Republic of Nigeria | 10:00a -10:30a | Break | 10:30a -12:00p | Pharmaceutical Sciences Forum: Vaccines and Pharmaceutical Products from Clinical Trials to Bedside, Part I Moderators: Okezie I. Aruoma, MBA, PhD, DSc, California State University Los Angeles, Los Angeles, and Global PharmHealth Associates, Long Beach, CA, USA. Olu Aloba, PhD, Premier Consulting, Morrisville, NC, USA. | 10:30a –11:15a | #200A2: Complex Pharmaceutical Products Development and Manufacturing Sydney Ugwu, PhD, ForDoz Pharma Corporation, East Windsor, NJ, USA. | 11:15a– 12:00p | Session #200A3: Complex Pharmaceutical Products Development and Manufacturing, Part II, Supply Chain, Moderated Discussion Anayo M. Ukeje, PhD, Abbvie Inc, North Chicago, IL, USA. Olu Aloba, PhD, Premier Consulting, Morrisville, NC, USA. USA. Nonye Onyewuenyi, PhD, Sandoz-Novartis Pharmaceuticals, Princeton, NJ, USA. Echeazu Ogu, PhD, Pharma & Biomed Consulting, Newark, DE, USA. | 12:00p – 3:00p | Lunch, Exhibition | 3:00p – 6:00p | Session # 250: Universal Activity Number: 0092-0000-22-202-L04-P (0.30 CEUs) Application-Based Activity. Pharmaceutical Sciences Forum II: Impact of a Changing Global Environment on Drug Discovery, Development, Manufacture, and Supply Chain |
| Moderators: Anayo M. Ukeje, PhD, Abbvie Inc, North Chicago, IL, USA. Echeazu Ogu, PhD, Pharma & Biomed Consulting, Newark, DE, USA. . | 3:00p – 3:45p | #200A1: The African Medicines Regulatory Harmonization Initiative. Moji Adeyeye PhD, National Agency for Food and Drug Administration and Control, Abuja, Nigeria. | 3:50p – 4:35p | #200A4: Barriers to Entry of Natural Products into the Pharmaceutical Market Olatunde E. Farombi, PhD, University of Ibadan, Ibadan, Nigeria. | 4:35p – 5:20p | #200A5: Vaccine Development and Manufacturing Using mRNA and other Technologies. Simon Agwale, PhD, Innovative Biotech Limited, Aberdeen, MD, USA. | 5:20p – 6:00p | #200A6 Panel Discussion: Future Impact of a Changing Global Environment on Drug Discovery, Development, Manufacturing and Supply Chain Okezie I. Aruoma, MBA, PhD, DSc, California State University Los Angeles, Los Angeles, and Global PharmHealth Associates, Long Beach, CA, USA. Sunny Ohia, PhD, Texan Southern University College of Pharmacy and health Sciences, Houston, USA Anayo M. Ukeje, PhD, Abbvie Inc, North Chicago, IL, USA. Olu Aloba, PhD, Premier Consulting, Morrisville, NC, USA. Echeazu Ogu, PhD, Pharma & Biomed Consulting, Newark, DE, USA. Nonye Onyewuenyi, PhD, Sandoz-Novartis Pharmaceuticals, Princeton, NJ, USA. Plus All Session 200 Speakers. | 6:00p – 7:00p | Break | 7:00p | Welcome Reception & Networking (Venue: TBD) |
SATURDAY, SEPTEMBER 24, 2022 7:00a – 5:00p | Registration | 6:00a – 9:00a | NAPPSA 5K Run | 9:00 a – 11:00a | Breakfast | 11:00a – 1:00p | Session #300: Universal Activity Number: 0092-0000-22-203-L04-P (0.20 CEUs) Application-Based Activity. Pharmacy Practice (Venue: TBD) | 11:00a -1:00p | Pharmacy Practice Part I Moderator: Kenneth Shobola, RPh, Kennedee Global, Lutz, FL, USA. | 11:00a – 1:00 p | Validating Controlled Substance Prescriptions and Resolving Red Flags Bob Parrado, RPh, Parrado Pharmacy Consultants, Inc., Tampa, FL, USA. | 1:00p – 3:00p | Lunch, Exhibition and Poster Session (see Page XX for List of Exhibitors and Posters) | 1:00p – 2:00p | ALUMNI MEETINGS: SPECIAL LUNCH TIME MEETINGS (Venue TBD) | 3:00p – 5:00p | Pharmacy Practice Part II Moderator: Emmanuel C. Ezirim, RPh, Central Point Pharmacy, Columbus, OH, USA. | 3:00p – 4:00p | Sponsorship Engagement | SATURDAY, SEPTEMBER 24, 2022 Parallel Session A | 4:00p – 5:00p | Session #400: Universal Activity Number: 0092-0000-22-204-L04-P (0.100 CEUs) Application-Based Activity. Pharmacy Business (Venue TBD) | 4:00p - 5:00p | Strengthening the Foundations for Pharmacy Business Success: Case Studies Emmanuel Ayanjoke, PharmD, Zik’s Family Pharmacy, Dayton, OH, USA
Discussion Session: Pharmacy Business Successes Panelists: Okwudili Ahiligwo, RPh, Bidwell Pharmacy and Medical Supply Inc, Chico, CA, USA. Nnodum Iheme, RPh, President, Zik’s Family Pharmacy, Dayton, OH. USA. Nkechi Onuoha, PharmD, Solano Pharmacy, Concord, CA, USA. Gbenga Olajide, PharmD, Westside Pharmacy and Wellness Center, Baltimore, MD, USA. Chinyere Anyanwu, PharmD, GIG Pharmacy Inc, Lovina, MI, USA. | 5:00p – 6:00p | General Membership Meeting (Venue: TBD) | 8:00 p | Conference Banquet – Venue TBD |
SATURDAY, SEPTEMBER 24, 2022 Parallel Session B 4:00p – 5:00p | Session #500: Young Professionals Workshop (Venue: TBD) Young Professionals Forum: Networking and Salary Negotiation Anayo M. Ukeje, PhD, Abbvie Inc, North Chicago, IL, USA. Adeleye Ogunkanmi, PharmD, Genmab US Inc, Princeton, NJ, USA
Moderators Chinedu Chukwu, PharmD, EMINENT Services Corporation, MD, USA. Sheriff Benson, PharmD, CVS Health, Columbus, OH, USA. |
SATURDAY, SEPTEMBER 24, 2022 Parallel Session C 4:00p – 5:00p | Session # 600: The Universal Activity Number: 0092-0000-22-206-L01-P (0.10 CEUs). Knowledge-Based Activity. Medical Updates in Healthcare Delivery Venue: TBD) |
| Moderator: Chinyere Onyebuchi, PhD, Takeda Pharmaceuticals, Cambridge, MA, USA. | 4:00p – 5:00p | Current Challenges in Clinical Therapy Leo Egbujiobi, RPh, MD, Beloit Memorial Hospital, Beloit, WI, USA. |
SUNDAY, SEPTEMBER 25, 2022 7:00a – 11:00a | Registration | 7:00a – 8:00a | Registration and Breakfast | 7:30a – 8:00a | Exhibition | 8:00am – 12:00p | Session #400: Universal Activity Number: 0092-0000-22-205-L01-P (0.40 CEUs) Application-Based Activity. Clinical Therapeutics. | 8:00a -10:00am | Clinical Therapeutics Part I Moderator: Gerald Muforo, PharmD, MBA, RPh, Walmart Pharmacy, Tampa FL, USA. | 8:00a – 10:00a | Session #400A: Medication Errors: Prevention and Mitigation Strategies. Bob Parrado, RPh, Parrado Pharmacy Consultants, Inc., Tampa, FL, USA. | 10:00a -10:15a | Break | 10:15a- 12:15p | Clinical Therapeutics Part II Moderators: Patrick Nwakama, PharmD, Food and Drug Administration, Silver Spring, MD, USA Adaeze Nworu, BS, University of Florida, Gainsville, FL, USA | 10:15a – 11:00a | Session #400B: Clinical Management of Mental Health and Case Studies Benton Stamper, PharmD, University of Florida Health, Jacksonville, FL, USA. | 11:00a – 11:45a | Session #400C: Evidence-based Disparities in Global Healthcare Delivery Folakemi Odedina, PhD, Center for Health Equity and Community Engagement Research, Mayo Clinic, Jacksonville, FL, USA. | 11:45a – 12:15p | Q & A Session | 12:15p | Conference Conclusion and Pictures |
Learning Objectives and CPE CREDITS THURSDAY, SEPTEMBER 22, 2022 12:30p – 2:30p | Session #100: Universal Activity Number: 0092-0000-22-200-L04-P (0.20 CEUs) Knowledge-Based Activity. Future of Pharmacy Education: Challenges and Innovations for Success, Part 1 | 12:30p – 1:40p | #100A1: Challenges and Innovations for Success Learning objectives [1] Describe the need for pharmacists to operate to the full potential of their professional education and skill sets [2] Explain the roles of pharmacists in elevating the well-being of health care consumers [3] Discuss the innovations in healthcare to emphasize prevention over treatment and care to increasingly take place in the home or community. | 1:40p – 2:30p | #100A2: Restructuring Nigeria’s Pharmacy Education and Developing Pharmacist Competencies in Non-traditional Roles Learning objectives [1] Articulate the opportunities for pharmacists to contribute to public and population health [2] Explain the roles of Pharmacists that supplement or extend the services of primary care providers in chronic condition management, prevention, and wellness, and diagnosing and treating minor acute illnesses [3] Articulate the context of specialty care as therapies become more complex requiring pharmacotherapy expertise as in oncology, cell and gene therapy, and rare diseases. | 2:30p | Break | 2:40p – 5:10p | Session #100: Universal Activity Number: 0092-0000-22-207-L04-P (0.25 CEUs) Application-Based Activity. Future of Pharmacy Education: Challenges and Innovations for Success, Part 2 | 2:40p -3:10p | #100A3: Innovations in Community Pharmacy Practice in the USA. Learning objectives [1] Discuss innovations in digital health, medical devices, and health apps [2] Explain the role of pharmacists to provide access to some point-in-care diagnostics, prescribe digital therapeutics, and help customers identify digital health tools [3] Articulate the opportunities for Pharmacists to move into analytical roles to identify health improvement opportunities | 3:10p – 3:40p | #100A4: Implementation of Pharmaceutical Care in Pharmacy Practice: A Collaborative Initiative in Nigeria. Learning objectives [1] Explain the role of pharmacists in clinical decision support and population health analytics, and design programs that improve population health. [2] Describe the converging traditional roles of pharmacists performing activities such as prescribing and de-prescribing, changing doses, ordering refills, and therapeutic substitutions. [3] Articulate the dynamics of the pharmacist in the forefront of doing real-time medication management. | 3:40p – 4:10p | #100A5: Educational Programs and Opportunities for Interdisciplinary Healthcare Professionals. Learning objectives [1] Articulate the barriers to the future vision of pharmacists as clinical service providers. [2] Re-imagine the role of pharmacists to have the abilities to prescribe medications, change doses, discontinue medications, give immunizations to any sort of patient, any age. | 4:10p – 4:40p | #100A6: Career Opportunities for Pharmaceutical Scientists in the USA: Finding the Right Path. Learning objectives [1] Assess career pathways in regulatory affairs, pharmacovigilance, medical drug information and medical science liaison [2] Assess career pathways in digital therapeutics, digital diagnostics, and drug safety | 4:40p – 5:10p | #100A7: Workforce Solutions for Pharmacy Practice in the USA: Thinking Outside the Box. Learning objectives [1] Assess the pharmacy workforce solutions in pharmacy practice from emergency care to home care [2] Articulate the pharmacy workforce in government and regulatory roles, technology, and health informatics roles as well as non-traditional pharmacy roles | 5:20p – 6:30p | Session #100A: Universal Activity Number: 0092-0000-22-208-L04-P (0.075 CEUs) Knowledge-Based Activity. Future of Pharmacy Education: Challenges and Innovations for Success, Part 3 | 5:20p – 6:30p | Panel Discussion: Challenges and Innovations in Pharmacy and Pharmaceutical Sciences Education Learning objectives [1] Assess challenges and innovations in the future of pharmacy and non-traditional pharmacy career roles [2] Examine the roles that require both pharmacy knowledge and passion for education enshrined in clinical rotations preceptorship, therapeutics, and pharmaceutics [3] Examine the roles teaching and training of pharmacists enshrined in residency, pharmacokinetics and pharmacodynamics, pharmacogenomics, research and development clinical rotations preceptorship, aerospace, and space health pharmacists |
FRIDAY, SEPTEMBER 23, 2022 9:00a – 12:00p | Session # 200: Universal Activity Number: 0092-0000-22-201-L04-P (0.30 CEUs) Knowledge-Based Activity. Pharmaceutical Sciences Forum I: Vaccines and Pharmaceutical Products from Clinical Studies to Bedside. | 9:00a – 10:00a | #200A1: Plenary Keynote Address: Health Care Delivery in Nigeria Health Care Delivery in Nigeria and Collaborations with Organizations in the Diaspora. Learning objectives [1] Describe the fundamental shift from “health care” to “health” and to healthcare delivery in developed and developing countries [2] Articulate the of healthcare delivery focused on well-being and managed by companies that assume new roles to drive value in a transformed health ecosystem. [3] Assess innovations in traditional life sciences and health care roles benchmarked on transformational organizational collaborations. | 10:30a –11:15a | #200A2: Complex Pharmaceutical Products Development and Manufacturing (Part 1) Learning objectives [1] Discuss products with complex active ingredients [2] Explain complex formulations [3] Describe complex dosage forms, and complex drug-device combination products | 11:15a – 12:00p | Session #200A3: Complex Pharmaceutical Products Development and Manufacturing (Part II) Learning objectives [1] Explain how to mitigate risks in terms of product quality, cost, safety, and mistakes can endanger patients and consumers in the development and manufacture of complex drugs [2] Describe the development of a prevention plan detailing, leadership functions and operational strategies for complex formulations in which cross-contamination poses a significant risk to quality, [3] Discuss how to implement strategies for preventing cross-contamination, employing single-use technology, and conducting non-destructive testing of the finished product will produce higher quality medicines and deliver better results to patients. | 3:00p – 6:00p | Session # 250: Universal Activity Number: 0092-0000-22-202-L04-P (0.30 CEUs) Application-Based Activity. Pharmaceutical Sciences Forum II: Impact of a Changing Global Environment on Drug Discovery, Development, Manufacture, and Supply Chain | 3:00p – 3:45p | #200A1: The African Medicines Regulatory Harmonization Initiative. Learning objectives [1] Describe the roles of governments and partners to build and strengthen medicines regulatory systems with appropriate legal frameworks and institutions so as to carry out regulatory functions while supported by mechanisms for collaboration among agencies. [2] Discuss the African Medicines Regulatory Harmonization Initiative to strengthen regulatory capacity, encourage harmonization of regulatory requirements and expediting access to good quality, safe, and effective medicines [3] Explain the relevance of various regulatory interventions undertaken at country, regional and continental levels is important for informing regulatory policy reforms undertaken by the African Union, governments, and partners | 3:50p – 4:35p | #200A4: Barriers to Entry of Natural Products into the Pharmaceutical Market Learning objectives [1] Recognize that the dynamics of the challenging regulatory approval processes and intellectual property obstacles pegged on a highly competitive pharmaceutical market. [2] Appreciate that many food plants used as herbs, health foods and for therapeutic purposes relevant in the treatment and management of several acute and chronic diseases. [3] Discuss the extensive natural products research in Nigeria and Africa and regulatory oversight on bringing nutraceutical products to market | 4:35p – 5:20p | #200A5: Vaccine Development and Manufacturing Using mRNA and other Technologies. [1] Discuss the basic principle of mRNA therapeutics involves delivery of in vitro transcribed mRNA into a target cell, where cellular machinery translates the mRNA into a functional protein, which in vaccine applications, an mRNA encoding a viral protein elicits a protective immune response, whereas in therapeutic applications, an mRNA encoding an absent (or dysfunctional) protein in a patient, provides functional protein expression. [2] Describe the development of novel vaccines against Ebola, HIV and COVID-19 using innovative viral-like particles, protein replacement therapy, and the treatment of genetic diseases. [3] Appreciate the general concepts of different classes of RNA-based therapeutics, including antisense oligonucleotides, aptamers, small interfering RNAs, microRNAs, and messenger RNA. | 5:20p – 6:00p | #200A6: Panel Discussion: Future Impact of a Changing Global Environment on Drug Discovery, Development, Manufacturing and Supply Chain Learning Objectives [1] Examine the context of building medical products regulatory capacity for achieving Universal Health Coverage goals, as well as sustainable development goals on access to quality, safe and efficacious health products to the global community [2] Articulate the principles of pharmaceutical therapies on the importance in patient care, benchmarking the small molecules and biologics drug indications |
SATURDAY, SEPTEMBER 24, 2022 11:00a – 1:00p | Session #300: Universal Activity Number: 0092-0000-22-203-L04-P (0.20 CEUs) Application-Based Activity. Pharmacy Practice (Venue: TBD) | 11:00a – 1:00p | Validating Controlled Substance Prescriptions and Resolving Red Flags Learning Objectives [1] Assess prescriptions for appropriate therapeutic value and detect prescriptions that are not based on a legitimate medical purpose. [2] Discuss the law and rules related to the prescribing and dispensing of controlled substances. [3] Describe how to ensure access to controlled substances for all patients with valid prescription and effectively use the Prescription Drug Monitoring Program’s Database. [4] Discuss that potent compounds are typically categorized based on therapeutic class and an acceptable daily exposure limit, a dose that is unlikely to cause an adverse effect if an individual is exposed, by any route, at or below this dose every day for a lifetime. [5] Assess prescriptions for appropriate therapeutic value and detect prescriptions that are not based on a legitimate medical purpose as well as discuss the law and rules related to the prescribing and dispensing of controlled substance | SATURDAY, SEPTEMBER 24, 2022 Parallel Session A | 4:00p – 5:00p | Session #400: Universal Activity Number: 0092-0000-22-204-L04-P (0.100 CEUs) Application-Based Activity. Pharmacy Business (Venue TBD) | 4:00p -5:00p | Strengthening the Foundations for Pharmacy Business Success: Case Studies Learning objectives [1] Appreciate that from an education perspective, entrepreneurial skills form a dual, interactive process, where students develop an understanding of the strengths and weaknesses of their ideas, and of themselves, in relation to owning a pharmacy business [2] Recognize that pharmacists have developed unique and innovative practices within the settings including population health management, direct, patient care services. [3] Appreciate that Pharmacists in direct patient care roles include chronic disease management services and prevention/wellness activities in collaboration with the patient’s healthcare team and minded according in business ownership |
SATURDAY, SEPTEMBER 24, 2022 Parallel Session B 4:00p – 5:00p | Session # 600: The Universal Activity Number: 0092-0000-22-206-L01-P (0.10 CEUs). Knowledge-Based Activity. Medical Updates in Healthcare Delivery Venue: TBD) | 4:00p – 5:00p | Challenges in Current Therapy in Cardiology Learning objectives [1] Describe the basic molecular mechanisms underlying the development and destabilization of atherosclerotic plaques in establishing therapeutic standards for patients with CVD. [2] Discuss disease progression and the discovery of novel drugs to suppress atherosclerotic, atherothrombotic and ischemic processes. [3] Understand targeted delivery of small molecule drugs, biologics (cell-, growth factor- or RNA-based therapeutics) and advanced therapeutic modalities (“smart” drug delivery (nano)systems) |
SUNDAY, SEPTEMBER 25, 2022 8:00a – 12:00p | Session #400: Universal Activity Number: 0092-0000-22-205-L01-P (0.40 CEUs) Application-Based Activity. Clinical Therapeutics. | 8:00a – 10:00a | Session #400A: Medication Errors: Prevention and Mitigation Strategies. Learning objectives [1] Verify that you are dispensing a valid and legally prescribed medication to a patient with a legitimate medical need. [2] Verify that the medication is appropriate for the medical need of the patient, while acting in the best interest of the patient, identify patient safety dangers and risks [3] Discuss the use device alarms and make sure that alarms on medical equipment are heard and checked quickly. | 10:15a – 11:00a | Session #400B: Clinical Management of Mental Health and Case Studies Learning objectives [1] Describe the sensitization of district management authorities and the establishment of community collaborative multi-sectoral forums assisted in improving political will to strengthen mental health services in both countries. [2] Explain how community-based self-help groups showed potential for empowering service users and careers to become more self-sufficient and less dependent on overstretched healthcare systems. [3] Discuss how mental health care professionals are using innovative ways to treat, diagnose, and counsel while educating frontline workers caring for residents | 11:00a -12:00p | Session #400C: Evidence-based Disparities in Global Healthcare Delivery Learning objectives [1] Articulate the concept that narrowing health disparities is key to improving our nation’s overall health and reducing unnecessary health care costs. [2] Recognize that disparities in health care exist and are associated with worse health outcomes. [3] Describe how bias, stereotyping, prejudice, and clinical uncertainty contribute to disparities.
|
Nova Southeastern University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of Continuing Pharmacy Education (CPE). This program has been assigned the following Universal Activity Numbers, 0092-0000-20-211-L04-P to 0092-0000-20-233-L04-P and has been accredited for 12 contact hours (1.2 CEUs). Attendees must register for the Conference, sign-in when required, actively participate throughout each activity, and complete and sign the Attendance Form (with an NABP ID Number and birthdate) to receive credit. Participant’s earned credits will be posted to the CPE Monitor Website 4 to 6 weeks after receipt of all Convention paperwork. All requests for Continuing Pharmacy Education Credits must be turned in by November 20, 2022.
Faculty: Presenters and Panelists Simon Agwale, PhD, Innovative Biotech, Keffi, Nigeria and Innovative Biotech, Havre de Grace, MD, USA Leo Egbujiobi, RPh, MD, Medical Director, The Hendricks Family Heart Hospital, Beloit Health Systems, Beloit, Wisconsin, USA. Nnodum Iheme, RPh, Nnodum Corporation & Ziks Family Pharmcy, Cincinnati, OH, USA Kevin Sneed, PharmD, University of South Florida Taneja College of Pharmacy, Tampa, FL, USA. Ahmed Tijjani Mora, MBA, PhD, Pharmacists Council of Nigeria, Abuja, Nigeria. Chidebelu Ufodike, PharmD, Walgreen, Deerfield, IL, USA. Azuka Oparah, MPharm, MBA, MPH, PhD, University of Benin, Benin. Nigeria. Chika P. Duru, DNP, Kaiser Permanente, CA, USA. Nonye Onyewuenyi, PhD, Sandoz-Novartis Pharmaceuticals, Princeton, NJ, USA. Nkem P. Nonyel, PharmD, MPH, Howard University College of Pharmacy, Washington DC, USA. Rukayyatu Gurin PhD, Senior Special Assistant to the President on Administration and Women Affairs in the Office of the First Lady of Nigeria, Abuja, Nigeria. Hajiya Aisha Muhammadu Buhari, First Lady of the Federal Republic of Nigeria Sydney Ugwu, PhD, ForDoz Pharma Corporation, East Windsor, NJ, USA. Moji Adeyeye, PhD, National Agency for Food and Drug Administration and Control, Abuja, Nigeria. Olatunde E. Farombi, PhD, University of Ibadan, Ibadan, Nigeria. Bob Parrado, RPh, Parrado Pharmacy Consultants, Inc., Tampa, FL, USA. Emmanuel Ayanjoke, PharmD, Zik’s Family Pharmacy, Dayton, OH, USA Okwudili Ahiligwo, RPh, Bidwell Pharmacy and Medical Supply Inc, Chico, CA, USA. Nkechi Onuoha, PharmD, Solano Pharmacy, Concord, CA, USA. Gbenga Olajide, PharmD, Westside Pharmacy and Wellness Center, Baltimore, MD, USA. Chinyere Anyanwu, PharmD, GIG Pharmacy Inc, Lovina, MI, USA. Benton Stamper, PharmD, University of Florida Health, Jacksonville, FL, USA. Folakemi Odedina, PhD, Center for Health Equity and Community Engagement Research, Mayo Clinic, Jacksonville, FL, USA. Adeleye Ogunkanmi, PharmD, Genmab US Inc, Princeton, NJ, USA Anayo M. Ukeje, PhD, Abbvie Inc, North Chicago, IL, USA.
Faculty: Moderators Okezie I Aruoma MBA, PhD, DSc, California State University Los Angeles, Los Angeles, CA, USA Ifeanyi G. Egbunike-Chukwuma, PharmD, University of Maryland Medical Center Midtown Campus, Baltimore, MD, USA. Olu Aloba, RPh, PhD, Premier Consulting, Morrisville, NC, USA Gerald Muforo, PharmD, MBA, Walmart, Tampa, FL, USA. Uche Ndefo, PharmD, Texas Southern University, Houston, TX, USAPatrick Nwakama, PharmD, Food & Drug Administration, Silver Spring, MD, USA. Chinyere Onyebuchi, PhD, Takeda Pharmaceuticals USA, Inc., Cambridge, MA, USA Teresa Pounds, PharmD, Wellstar Atlanta Medical Center, Atlanta, GA, USA. Anayo M. Ukeje, PhD, Abbvie Inc, North Chicago, IL, USA. Echeazu Ogu, PhD, Pharma & Biomed Consulting, Newark, DE, USA. Sunny Ohia, PhD, Texan Southern University College of Pharmacy and health Sciences, Houston, USA Nonye Onyewuenyi, PhD, Sandoz-Novartis Pharmaceuticals, Princeton, NJ, USA. Kenneth Shobola, RPh, Kennedee Global, Lutz, FL, USA. Emmanuel C. Ezirim, RPh, Central Point Pharmacy, Columbus, OH, USA. Chinedu Chukwu, PharmD, EMINENT Services Corporation, MD, USA. Sheriff Benson, PharmD, CVS Health, Columbus, OH, USA. Adaeze Nworu, BS, University of Florida, Gainsville, FL, USA
|